Enzymatica's Nomination Committee proposed to the Annual General Meeting on May 5, 2020 that Fredrik Lindberg, the company's present CEO, will replace Sigurgeir Guðlaugsson, who will not be seeking re-election. As announced earlier, Fredrik Lindberg will leave the company at summer after having accepted a job offer from a private pharmaceutical company that does not compete with Enzymatica. Fredrik Lindberg has been CEO and Chief Medical Officer for Enzymatica since 2015.